Wegovy weight loss results from major clinical trials show that people taking the medication lose an average of 14.9 percent of their initial body weight over 68 weeks, compared to about 2.4 percent with placebo. This means a person starting at 200 pounds can expect to lose roughly 30 pounds on average, though individual results vary widely.
Key Takeaways
- In the STEP 1 trial, 86.4 percent of people taking Wegovy lost at least 5 percent of their body weight after 68 weeks.
- Nearly half of participants (48.1 percent) lost at least 15 percent of their initial body weight on Wegovy versus 4.9 percent on placebo.
- Weight loss typically begins within 4 to 8 weeks and continues gradually over the first year of treatment.
- Stopping Wegovy often leads to regaining about two thirds of lost weight within one year off the drug.
- Real world data suggests average weight loss of 10 to 12 percent after six months, slightly less than clinical trials due to adherence differences.
What Do Clinical Trials Say About Wegovy Weight Loss Results?
The largest clinical trial for Wegovy, known as STEP 1, enrolled nearly 2,000 adults without diabetes who had a body mass index (BMI) of 30 or higher, or a BMI of 27 with at least one weight related condition. Participants received weekly injections of 2.4 mg semaglutide, the active ingredient in Wegovy, along with lifestyle counseling. After 68 weeks, those on Wegovy lost an average of 14.9 percent of their starting weight. For context, this equates to approximately 33 pounds for a person weighing 220 pounds. In the placebo group, average loss was only 2.4 percent, or about 5 pounds.
A secondary analysis found that 86.4 percent of Wegovy users lost at least 5 percent of their body weight, a threshold often considered clinically meaningful. Over one third (38.6 percent) lost at least 20 percent of their weight. These numbers are significantly higher than those seen with older weight loss medications. Comparatively, the STEP 4 trial examined what happens after stopping the drug: those who continued Wegovy lost an additional 7.9 percent of their weight over 48 weeks, while those switched to placebo gained back 6.9 percent.
How Much Weight Do People Lose on Wegovy in Real World Settings?
Real world evidence, collected from electronic medical records and patient surveys, shows slightly lower but still substantial weight loss. A large study published in 2023 tracking over 3,000 adults found that after six months, people on Wegovy lost an average of 10.6 percent of their initial body weight. After one year, average loss reached about 13.2 percent. These figures are modestly lower than the 15 percent seen in clinical trials, likely because real world patients may not always receive intensive lifestyle counseling or may have adherence challenges. However, even this real world weight loss is more than double what is typically achieved with diet and exercise alone.
It is important to note that insurance coverage and access to Wegovy vary, which can affect how consistently people take the medication. For a deeper look at how Wegovy and similar drugs work, see our full guide on GLP-1 Medications Explained.
How Quickly Does Wegovy Start Showing Results?
Most people notice some weight loss within the first 4 to 8 weeks of starting Wegovy. The drug is started at a low dose of 0.25 mg once weekly and gradually increased every four weeks to minimize side effects like nausea. During this titration phase, which lasts about 16 to 20 weeks, weight loss is typically modest, averaging 2 to 4 percent of starting weight. Once the full maintenance dose of 2.4 mg is reached, weight loss accelerates. The greatest rate of loss occurs between weeks 20 and 40, after which it plateaus. By week 68, most people reach their maximum weight loss.
Early responders, defined as those who lose at least 5 percent of their weight by week 12, are more likely to lose 15 percent or more by week 68. If little weight loss occurs after three months at the full dose, doctors may reassess treatment.
What Percentage of Users Lose Significant Weight?
Clinical trial data show that weight loss on Wegovy falls along a spectrum. In the STEP 1 trial, 86.4 percent lost at least 5 percent of body weight. 69.1 percent lost at least 10 percent. 48.1 percent lost at least 15 percent. 38.6 percent lost at least 20 percent. Only 8.3 percent of people taking Wegovy lost less than 5 percent, meaning the vast majority achieve a medically meaningful outcome. In comparison, in the placebo group, only 4.9 percent lost 15 percent or more.
These figures highlight that Wegovy does not work equally for everyone, but the odds of achieving significant weight loss are high. Factors that predict greater weight loss include younger age, male sex, higher starting weight, and better medication adherence.
Does Weight Loss Continue Beyond One Year?
The longest controlled trial of Wegovy, the STEP 5 extension study, followed people for 104 weeks (two years). At two years, those on Wegovy maintained an average weight loss of 15.2 percent of their starting weight, nearly identical to the 14.9 percent at 68 weeks. This suggests that weight loss reaches a plateau after about a year, but the loss is well maintained with continued use. Without the drug, weight regain is common: the STEP 4 trial showed that after stopping Wegovy, participants regained 11.6 percent of their body weight over 48 weeks, meaning they kept only about one third of their original loss.
Long term data beyond two years for Wegovy specifically are limited, but studies of semaglutide in diabetes show sustained effects for up to four years with continued use.
Frequently Asked Questions
How much weight can I lose with Wegovy in one month?
In the first month, most people lose 2 to 5 pounds (1 to 3 percent of body weight). This early loss is partly due to reduced appetite and water loss. Because of the dose escalation schedule, full effects are not seen until the maintenance dose is reached after roughly four months. Setting realistic expectations for the first month is important for staying motivated.
Is Wegovy weight loss permanent?
Weight loss with Wegovy is not permanent if the medication is stopped without making lasting lifestyle changes. Clinical trials show that within one year off the drug, people regain about two thirds of the weight they lost. Maintaining weight loss likely requires continuing the medication long term or adopting very strict dietary and exercise habits. Some people transition to a lower maintenance dose for long term weight management.
Why do some people not lose weight on Wegovy?
About 8 to 12 percent of people in clinical trials lost less than 5 percent of their body weight, classifying them as non-responders. Possible reasons include genetic differences in metabolism, inconsistent dosing, side effects that limit dose escalation, or underlying medical conditions like hypothyroidism or certain medications that counteract weight loss. Doctors may stop Wegovy after three months if a patient has not lost at least 5 percent of their starting weight.
This article is for general information and is not medical advice. See our Medical Disclaimer.


